Afficher la notice abrégée

New insights into cytotoxic mechanisms of bozepinib against glioblastoma

dc.contributor.authorCruz López, Olga María 
dc.contributor.authorConejo García, Ana 
dc.contributor.authorCampos Rosa, Joaquín María 
dc.contributor.authorde Fragas Días, Amanda
dc.contributor.authorNathali Scholl, Juliete
dc.contributor.authorJacintho Moritz, Cesar Eduardo
dc.contributor.authorPorto Kagami, Luciano
dc.contributor.authorMachado das Neves, Gustavo
dc.contributor.authorEifler-Lima, Vera Lúcia
dc.contributor.authorSevigny, Jean
dc.contributor.authorOliveira Battastini, Ana María
dc.contributor.authorFigueiro, Frabricio
dc.date.accessioned2024-02-01T12:01:26Z
dc.date.available2024-02-01T12:01:26Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/10481/87927
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleNew insights into cytotoxic mechanisms of bozepinib against glioblastomaes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.ejps.2021.105823


Fichier(s) constituant ce document

[PDF]
Nom:
EurJPharmSci2021_50.pdf
Taille:
6.383Mo
Format:
PDF

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional